DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinorelbine (Vinorelbine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Vinorelbine and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (259)
Death (81)
Life Threatening Events (43)
Disability (3)

Reports by Reaction Type

Neutropenia (25)Hepatic Failure (22)Neutropenic Sepsis (21)Febrile Neutropenia (20)Pyrexia (18)Pneumonia (18)Anaemia (16)Interstitial Lung Disease (15)Pancytopenia (13)Constipation (11)Death (11)Hypotension (11)

Below are a few examples of reports where side effects / adverse reactions may be related to Vinorelbine. For a complete list or a specific selection of reports, please use the links above.

Possible Vinorelbine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-27

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cisplatin
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dexamethasone Sodium Phosphate
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin HCL
    Dosage: unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Ifosfamide
    Dosage: unk
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Dosage: 2 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Rituximab
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01

Vinblastine
    Dosage: 8 cycles
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Dosage: unk
    Indication: Hodgkin's Disease
    Start date: 2007-01-01



Possible Vinorelbine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Cytarabine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Dacarbazine
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease
    Start date: 2006-01-01

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Dexamethasone



Possible Vinorelbine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Vinorelbine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-23

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Vinorelbine side effects in female

Reported by a pharmacist from United States on 2012-08-22

Patient: female, weighing 51.3 kg (112.8 pounds)

Reactions: Arthralgia, Nausea, Groin Pain

Drug(s) suspected as cause:
Vinorelbine
    Indication: non-Small Cell Lung Cancer Stage IV

Vinorelbine Tartrate
    Indication: non-Small Cell Lung Cancer Stage IV



Possible Vinorelbine side effects in 29 year old female

Reported by a physician from Hungary on 2012-08-21

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Carboplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cisplatin
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Cytarabine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dacarbazine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Doxorubicin HCL

Etoposide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Etoposide
    Start date: 2007-01-01

Gemcitabine Hydrochloride
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Ifosfamide
    Start date: 2007-01-01

Ifosfamide
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Rituximab
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01

Vinblastine Sulfate
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2006-01-01

Vinorelbine
    Indication: non-Hodgkin's Lymphoma Stage IV
    Start date: 2007-01-01



Possible Vinorelbine side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-15

Patient: 68 year old female

Reactions: Neoplasm Malignant, Pulmonary Embolism

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cetuximab
    Dosage: strength 2mg/ml. most recent infusion 21apr06
    Indication: non-Small Cell Lung Cancer
    Start date: 2006-01-19

Cisplatin
    Dosage: most recent infusion 06apr06. received 4 infusions
    Indication: non-Small Cell Lung Cancer
    Start date: 2006-01-19

Vinorelbine
    Dosage: most recent infusion 13apr06. received 8 infusions
    Indication: non-Small Cell Lung Cancer
    Start date: 2006-01-19



Possible Vinorelbine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Vinorelbine side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Vinorelbine side effects in 38 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-09

Patient: 38 year old male

Reactions: Cellulitis, Febrile Neutropenia, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cetuximab
    Dosage: delayed on 30-nov-05. most recent infusion 24-nov-05 (6th infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20

Cisplatin
    Dosage: most recent infusion 18-nov-05 (2nd infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20

Vinorelbine
    Dosage: most recent infusion 24-nov-05 (4th infusion).
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-10-20



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-08-08

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-08-30



Possible Vinorelbine side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-06

Patient: 60 year old male

Reactions: Extravasation

Drug(s) suspected as cause:
Vinorelbine

Other drugs received by patient: Cisplatin



Possible Vinorelbine side effects in 74 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-06

Patient: 74 year old male, weighing 74.0 kg (162.8 pounds)

Reactions: Diverticulitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cetuximab
    Dosage: cetuximab 5mg/ml
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-13
    End date: 2012-01-31

Cisplatin
    Dosage: recent inf on 24-jan-2012
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-13
    End date: 2012-01-24

Gemcitabine Hydrochloride
    Dosage: 1 and day 8 of each 3-week cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-12-13
    End date: 2012-01-31

Vinorelbine
    Dosage: 1 and day 8 of each 3week cycle
    Indication: non-Small Cell Lung Cancer

Other drugs received by patient: Isoten; Spiriva; Medrol; Voltaren; Minocycline HCL; Acetaminophen; Omeprazole; Ultra-MG; Duragesic-100; Litican; Primperan TAB



Possible Vinorelbine side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-06

Patient: male

Reactions: Gastric Perforation, Gastric Ulcer Haemorrhage, Anal Haemorrhage, Gastrointestinal Necrosis, Gastric Ulcer, Abdominal Pain Upper, Peritonitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Radiotherapy
    Indication: Adrenal Mass

Vinorelbine
    Dosage: 25 mg/m2, unk
    Indication: Adrenal Mass



Possible Vinorelbine side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-03

Patient: 58 year old male

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Drug(s) suspected as cause:
Cetuximab
    Dosage: no of courses 12
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-10-24

Cisplatin
    Dosage: no of courses 4
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-10-24

Vinorelbine
    Dosage: no of courses 8
    Indication: non-Small Cell Lung Cancer
    Start date: 2011-10-24

Other drugs received by patient: Emend; Dexamethasone; Ranitidine; Ondansetron; Prochlorperazine; Multi-Vitamin



Possible Vinorelbine side effects in 66 year old male

Reported by a consumer/non-health professional from Germany on 2012-08-02

Patient: 66 year old male, weighing 77.0 kg (169.4 pounds)

Reactions: Febrile Bone Marrow Aplasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cetuximab
    Dosage: cetuximab 5mg/ml recent dose 250mg/m2,inf 14, 10may12
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-31

Cisplatin
    Dosage: recent dose 80mg/m2, on 3may12 inf 5,
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-31

Vinorelbine
    Dosage: 25mg/m2 day 1 and day 8 of each 3wk cycle. recent dose 25mg/m2, inf 10, 10may12
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-31



Possible Vinorelbine side effects in female

Reported by a physician from Spain on 2012-07-31

Patient: female, weighing 74.0 kg (162.8 pounds)

Reactions: Pulmonary Toxicity, Organising Pneumonia, Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-16
    End date: 2012-03-01

Herceptin
    Start date: 2012-03-29
    End date: 2012-03-29

Taxol
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-25
    End date: 2012-03-01

Vinorelbine
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-29
    End date: 2012-03-29



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 50.0 kg (110.0 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2012-07-24

Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-13

Comparator Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-19

Comparator Trastuzumab
    Start date: 2012-07-24

Vinorelbine
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13
    End date: 2012-07-19

Vinorelbine
    Start date: 2012-07-24

Zoledronic Acid
    Indication: Metastases To Bone
    Start date: 2011-05-01

Other drugs received by patient: Loxoprofen; Lansoprazole; Rebamipide; Lyrica; Fentanyl-100; Magmitt



Possible Vinorelbine side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-07-26

Patient: 34 year old female

Reactions: Vomiting, Nausea, Hyperphosphataemia, Headache, Hypercalcaemia, Grand MAL Convulsion, Posterior Reversible Encephalopathy Syndrome, Dizziness, Altered State of Consciousness, Hypertension, Oxygen Saturation Decreased, Gaze Palsy

Drug(s) suspected as cause:
Vinorelbine

Other drugs received by patient: Paclitaxel; Cisplatin; Gemcitabine



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-25

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13
    End date: 2012-07-13

Comparator Trastuzumab
    Dosage: unk
    Start date: 2012-03-13

Vinorelbine
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Zoledronic Acid
    Dosage: unk
    Indication: Metastases To Bone
    Start date: 2012-03-13

Other drugs received by patient: Loxoprofen; Lansoprazole; Lyrica; Rebamipide; Magmitt; Fentanyl-100



Possible Vinorelbine side effects in female

Reported by a physician from Poland on 2012-07-25

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lapatinib
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-29

Vinorelbine
    Dosage: 20mgm2 cyclic
    Indication: Breast Cancer Metastatic
    Start date: 2011-12-28



Possible Vinorelbine side effects in 33 year old male

Reported by a physician from Ireland on 2012-07-25

Patient: 33 year old male

Reactions: Fatigue, Drug Ineffective, Snoring, Gait Disturbance, Somnolence, Amnesia

Drug(s) suspected as cause:
Adcetris
    Dosage: qcycle
    Indication: Hodgkin's Disease

Gemcitabine
    Dosage: qcycle
    Indication: Hodgkin's Disease

Ifosfamide
    Dosage: qcycle
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease



Possible Vinorelbine side effects in female

Reported by a physician from Spain on 2012-07-24

Patient: female

Reactions: Pulmonary Toxicity, Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer Metastatic

Taxol
    Indication: Breast Cancer Metastatic

Vinorelbine
    Indication: Breast Cancer Metastatic



Possible Vinorelbine side effects in female

Reported by a physician from Japan on 2012-07-19

Patient: female, weighing 51.0 kg (112.2 pounds)

Reactions: Subdural Haematoma, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-13

Comparator Trastuzumab
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Vinorelbine
    Dosage: unk
    Indication: Breast Cancer Metastatic
    Start date: 2012-03-13

Zoledronic Acid
    Dosage: unk
    Indication: Metastases To Bone
    Start date: 2012-03-13

Other drugs received by patient: Magmitt; Loxoprofen; Rebamipide; Lansoprazole; Lyrica; Fentanyl-100



Possible Vinorelbine side effects in 56 year old male

Reported by a physician from Greece on 2012-07-18

Patient: 56 year old male

Reactions: Pneumonia Aspiration, Metastases To Liver, Metastases To Lung, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 15 mg/kg, every 21 days
    Indication: non-Small Cell Lung Cancer

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer

Vinorelbine
    Dosage: unk
    Indication: non-Small Cell Lung Cancer

Other drugs received by patient: Docetaxel; Cisplatin



Possible Vinorelbine side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-16

Patient: 58 year old male

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Drug(s) suspected as cause:
Cetuximab
    Dosage: no of courses 12
    Indication: non-Small Cell Lung Cancer

Cisplatin
    Dosage: no of courses 4
    Indication: non-Small Cell Lung Cancer

Vinorelbine
    Dosage: no of courses 8
    Indication: non-Small Cell Lung Cancer

Other drugs received by patient: Prochlorperazine; Ranitidine; Emend; Ondansetron; Dexamethasone; Multi-Vitamin



Possible Vinorelbine side effects in female

Reported by a physician from Belgium on 2012-07-11

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Cytolytic Hepatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-01
    End date: 2011-07-21

Afinitor
    Dosage: no treatment
    Start date: 2011-07-22
    End date: 2011-08-04

Afinitor
    Dosage: code not broken
    Start date: 2011-08-05
    End date: 2011-09-06

Blinded NO Treatment Received
    Dosage: code not broken
    Start date: 2011-08-05
    End date: 2011-09-06

Blinded NO Treatment Received
    Dosage: no treatment
    Start date: 2011-07-22
    End date: 2011-08-04

Blinded NO Treatment Received
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-01
    End date: 2011-07-21

Comparator Trastuzumab
    Dosage: 2 mg/kg, unk
    Indication: Breast Cancer Metastatic

Placebo
    Dosage: no treatment
    Start date: 2011-07-22
    End date: 2011-08-04

Placebo
    Dosage: code not broken
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-01
    End date: 2011-07-21

Placebo
    Dosage: code not broken
    Start date: 2011-08-05
    End date: 2011-09-06

Pravastatin

Vinorelbine
    Dosage: 2.5 mg/m2, unk
    Indication: Breast Cancer Metastatic
    Start date: 2011-07-01



Possible Vinorelbine side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-10

Patient: 57 year old male

Reactions: Wrong Technique in Drug Usage Process, Neutropenic Sepsis, Skin Tightness, Incorrect Drug Administration Duration, Infusion Site Pain, Infusion Site Pruritus, Infusion Site Vesicles, Infusion Site Erythema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vinorelbine

Other drugs received by patient: Cisplatin



Possible Vinorelbine side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10

Patient: 61 year old female

Reactions: Nausea, Pain, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-12-28

Erbitux
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-12-28

Vinorelbine
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-12-28

Other drugs received by patient: Domperidone; Ventolin; Granisetron; Magnesium Chloride; Potassium Chloride; Cyclizine; Tramadol HCL



Possible Vinorelbine side effects in

Reported by a physician from United States on 2012-07-09

Patient:

Reactions: Radiation Pneumonitis, Hodgkin's Disease

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: salvage chemotherapy

Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: salvage chemotherapy

Doxorubicin HCL
    Indication: Hodgkin's Disease

Etoposide

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Radiotherapy
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017